|
Important Dates for World Congress 2010 |
 |
 |
 |
Deadline for Additional Items for the Agenda – 29th World Congress
Bylaw § 4.1 "Each BLS Association Member may request that additional items be added to the agenda so long as such requests are delivered to
the President four months or more prior to the date of such Regular GAD" Requests must be sent no later than February 10th 2010. Nominations "Any member of a BLS Association Member, a Provisional BLS Association Member or a Group Member, each Individual
member and each incumbent Council Member, shall be eligible for nomination and election as a Council Member. In order to stand for election, such an individual must:(a) be nominated by one or more BLS Association Members and agree in writing to stand for election, four months or more prior to the date of the GAD…."
Nominations must be sent no later than February 10th 2010. Deadline for Awards Program
The Elisabeth Pletscher Award - sponsored by the Nordic Group of Biomedical Laboratory Scientists' Associations,
The Nordic Award - sponsored by the Nordic Group of Biomedical Laboratory Scientists' Associations,
The Sysmex Scientific Award - sponsored by Sysmex Corporation,
The Tokosha Good Poster Awards - sponsored by Tokosha Incorporated,
The IFBLS Student Award - sponsored by IFBLS,
The IFBLS Past President’s Award - sponsored by IFBLS.
Applications must be post marked or sent electronically to the IFBLS Office by February 15, 2010. |
|
|
Canadian Health Ministry Reports Severe Reaction to Swine Flu Vaccine |
|
|
|
|
The Toronto Sun (2/2, Lem) reports the Canadian provincial health ministry "is investigating 17 cases in which people fell seriously ill after the receipt of the H1N1 flu vaccine." A ministry spokesman "said the cases include four vaccine recipients who came down with Guillain-Barre Syndrome (GBS) - a rare neurological condition characterized by sudden weakness or paralysis," and 13 cases of the serious allergic reaction anaphylaxis. The ministry "said there are measures in place" to watch for any further reactions.
|
|
Blood Test May Detect RA Before Symptoms are Noticed |
|
|
|
|
HealthDay (2/1, Preidt) reported that, according to a study published in the February issue of Arthritis & Rheumatism, "a blood test can predict rheumatoid arthritis (RA) long before a person notices symptoms." After analyzing "blood samples taken from 86 people before the onset of RA symptoms, from 69 of the same people after RA symptoms began, and from a group of 256 people who did not have the disease," Swedish investigators "identified several cytokines, cytokine-related factors and chemokines whose levels increase significantly as much as several years before the onset of" RA.
|
|
Blood Test for Colorectal Cancer May Help Identify Patients Who Most Benefit from Colonoscopy |
|
|
|
|
HealthDay (1/20, Preidt) reported, "The first blood test to reliably detect early-stage colorectal cancer and polyps may help identify patients who would gain most from colonoscopy," according to findings reported at the Gastrointestinal Cancers Symposium. In a news release from the American Society of Clinical Oncology, "which helped organize the meeting," lead author Sarah Kraus, of the Tel Aviv Souraski Medical Center, said the test "holds promise for identifying the patients at risk for colorectal cancer and could help guide the best use of colonoscopy resources." The test detects "a protein called CD24 that is elevated in the presence of both colon cancer and growths that are destined to become colon cancer," WebMD (1/20, Laino) reported. In a study of 73 people, researchers found that "the test accurately detected colorectal cancer in 92 percent of cases; only eight percent of colon cancers were missed." The test also "accurately caught 84 percent" of adenomas, with an 11 percent false-positive rate. |
|
Experimental Blood Test May Help Detect More Pancreatic Cancer Cases Early |
|
|
|
|
USA Today (1/21, Szabo) reports, "An experimental blood test" may help detect more pancreatic cancer cases "early, at least in high-risk patients...according to" research presented at the Gastrointestinal Cancers Symposium. The test works by measuring "a protein made by pancreatic tumors called PAM-4." In a study of "68 patients who had surgery for pancreatic cancer and 19 healthy volunteers," researchers found that the test "detected 62 percent of early tumors and 90 percent of more advanced cancers." WebMD (1/20, Laino) reported that the PAM-4 protein "appears to be very specific for pancreatic cancer," because "it's rarely found in normal tissue or other cancers," the researchers noted. They added that "the antibody also shows promise for treating the disease by acting as a carrier for radiation or drugs that can target and kill pancreatic cancer cells." |
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>
|
|
Page 3 of 7 |
